{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:07:57Z","timestamp":1791223677475,"version":"4.1.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology & Behavior"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.physbeh.2019.01.005","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T18:38:44Z","timestamp":1547231924000},"page":"52-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["NMDA receptor in the hippocampus alters neurobehavioral phenotypes through inflammatory cytokines in rats with sporadic Alzheimer-like disease"],"prefix":"10.1016","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1664-8683","authenticated-orcid":false,"given":"Mohammad","family":"Amani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Zolghadrnasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4970-0337","authenticated-orcid":false,"given":"Ali-Akbar","family":"Salari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2019.01.005_bb0005","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.3233\/JAD-2012-129009","article-title":"Elucidating the triggers, progression, and effects of Alzheimer's disease","volume":"33","author":"Medeiros","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0010","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1586\/14737175.2014.915740","article-title":"Understanding the cause of sporadic Alzheimer's disease","volume":"14","author":"Zetterberg","year":"2014","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000316119","article-title":"Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy","volume":"30","author":"Olazar\u00e1n","year":"2010","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/1567205012666150204124310","article-title":"The prevalence of depression in Alzheimer's disease: a systematic review and meta-analysis","volume":"12","author":"Chi","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0025","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1176\/jnp.15.2.180","article-title":"Frequency and characteristics of anxiety among patients with Alzheimer's disease and related dementias","volume":"15","author":"Porter","year":"2003","journal-title":"J. Neuropsychiatry Neurosci. Clin."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2018.01.001","article-title":"ATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression- and anxiety-related symptoms in a rat model of Alzheimer's disease","volume":"137","author":"Esmaeili","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.physbeh.2019.01.005_bb9000","doi-asserted-by":"crossref","DOI":"10.1097\/FBP.0000000000000450","article-title":"The blockade of corticotropin-releasing factor 1 receptor attenuates anxiety-related symptoms and hypothalamus\u2013pituitary\u2013adrenal axis reactivity in mice with mild traumatic brain injury","author":"Kosari-Nasab","year":"2018","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.physbeh.2019.01.005_bb9005","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2018.10.040","article-title":"Hesperidin attenuates depression-related symptoms in mice with mild traumatic brain injury","author":"Kosari-Nasab","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.physbeh.2019.01.005_bb9010","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-018-5137-8","article-title":"Minocycline prevents the developmentof depression-like behavior and hippocampal inflammation in a rat model of Alzheimer\u2019s disease","author":"Amani","year":"2018","journal-title":"Psychopharmacol. (Berl)."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0035","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.arr.2011.01.001","article-title":"Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?","volume":"10","author":"Correia","year":"2011","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0040","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2011.12.063","article-title":"Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation","volume":"1441","author":"Correia","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0045","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2174\/156720512803569055","article-title":"The animal models of dementia and Alzheimer's disease for pre-clinical testing and clinical translation","volume":"9","author":"Anand","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00702-012-0877-9","article-title":"What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research","volume":"120","author":"Salkovic-Petrisic","year":"2013","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0055","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2009.10.022","article-title":"Depression and Alzheimer's disease: neurobiological links and common pharmacological targets","volume":"626","author":"Caraci","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/089198870101400111","article-title":"Anxiety and Alzheimer's disease","volume":"14","author":"Ferretti","year":"2001","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/JAD-148003","article-title":"Neuropathology of depression in Alzheimer's disease: current knowledge and the potential for new treatments","volume":"44","author":"Khundakar","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0070","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-3223(02)01348-3","article-title":"Depression in Alzheimer's disease: overview and treatment","volume":"52","author":"Lyketsos","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1176\/ajp.152.1.37","article-title":"Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease","volume":"152","author":"Migliorelli","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0080","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1001\/jamapsychiatry.2014.2476","article-title":"Amyloid-\u03b2, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter","volume":"72","author":"Pietrzak","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0085","doi-asserted-by":"crossref","first-page":"M348","DOI":"10.1093\/gerona\/54.7.M348","article-title":"Anxiety in Alzheimer's disease: prevalence and comorbidity","volume":"54","author":"Teri","year":"1999","journal-title":"J. Gerontol. Ser. A Biomed. Sci. Med. Sci."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0090","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.neurobiolaging.2012.11.015","article-title":"Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer's disease rat model","volume":"34","author":"Brureau","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0095","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1007\/s12035-016-9848-8","article-title":"Antidepressant-like effect of Ropren\u00ae in \u03b2-amyloid-(25\u201335) rat model of Alzheimer's disease with altered levels of androgens","volume":"54","author":"Soultanov","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bbi.2016.03.002","article-title":"Indoleamine-2, 3-dioxygenase mediates neurobehavioral alterations induced by an intracerebroventricular injection of amyloid-\u03b2 1-42 peptide in mice","volume":"56","author":"Souza","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2017.05.024","article-title":"Swimming exercise prevents behavioural disturbances induced by an intracerebroventricular injection of amyloid-\u03b2 1-42 peptide through modulation of cytokine\/NF-kappaB pathway and indoleamine-2, 3-dioxygenase in mouse brain","volume":"331","author":"Souza","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11011-016-9880-4","article-title":"Sb203580 reverses memory deficits and depression-like behavior induced by microinjection of A\u03b21\u201342 into hippocampus of mice","volume":"32","author":"Guo","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0115","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.physbeh.2017.07.023","article-title":"Silibinin ameliorates anxiety\/depression-like behaviors in amyloid \u03b2-treated rats by upregulating BDNF\/TrkB pathway and attenuating autophagy in hippocampus","volume":"179","author":"Song","year":"2017","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0120","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1476-5381.2010.00669.x","article-title":"Soluble \u03b2amyloid1-42: a critical player in producing behavioural and biochemical changes evoking depressive-related state?","volume":"159","author":"Colaianna","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.physbeh.2014.04.021","article-title":"Inhalation of coriander volatile oil increased anxiolytic\u2013antidepressant-like behaviors and decreased oxidative status in beta-amyloid (1\u201342) rat model of Alzheimer's disease","volume":"131","author":"Cioanca","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2013.01.039","article-title":"Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-\u03b2 (A\u03b21\u201340) administration in mice","volume":"244","author":"dos Santos","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12993-015-0059-7","article-title":"Anxiolytic and antidepressant profile of the methanolic extract of Piper nigrum fruits in beta-amyloid (1\u201342) rat model of Alzheimer's disease","volume":"11","author":"Hritcu","year":"2015","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0140","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1523\/JNEUROSCI.1269-16.2016","article-title":"Cross talk between brain innate immunity and serotonin signaling underlies depressive-like behavior induced by Alzheimer's amyloid-\u03b2 oligomers in mice","volume":"36","author":"Ledo","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0145","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1007\/s12035-016-0134-6","article-title":"Atorvastatin Protects from A\u03b21\u201340-Induced Cell damage and Depressive-like Behavior via ProBDNF Cleavage","volume":"54","author":"Ludka","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0150","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pnpbp.2017.05.004","article-title":"Antidepressant drugs for beta amyloid-induced depression: a new standpoint?","volume":"78","author":"Schiavone","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0155","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1080\/01616412.2016.1209337","article-title":"Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior","volume":"38","author":"Sharma","year":"2016","journal-title":"Neurol. Res."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuro.2016.10.008","article-title":"Berberine protects against memory impairment and anxiogenic-like behavior in rats submitted to sporadic Alzheimer's-like dementia: involvement of acetylcholinesterase and cell death","volume":"57","author":"de Oliveira","year":"2016","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.lfs.2013.11.014","article-title":"Anthocyanins restore behavioral and biochemical changes caused by streptozotocin-induced sporadic dementia of Alzheimer's type","volume":"96","author":"Gutierres","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2011.04.014","article-title":"Sporadic dementia of Alzheimer's type induced by streptozotocin promotes anxiogenic behavior in mice","volume":"223","author":"Pinton","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/FBP.0b013e32835efc2f","article-title":"Depressive-like behaviour induced by an intracerebroventricular injection of streptozotocin in mice: the protective effect of fluoxetine, antitumour necrosis factor-\u03b1 and thalidomide therapies","volume":"24","author":"Souza","year":"2013","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0180","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s12640-016-9691-8","article-title":"Intracerebroventricular administration of streptozotocin as an experimental approach to depression: evidence for the involvement of proinflammatory cytokines and indoleamine-2, 3-dioxygenase","volume":"31","author":"Souza","year":"2017","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0185","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1007\/s11064-017-2329-2","article-title":"Activation of brain indoleamine-2, 3-dioxygenase contributes to depressive-like behavior induced by an intracerebroventricular injection of streptozotocin in mice","volume":"42","author":"Souza","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0190","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(85)90965-1","article-title":"A new definition of Alzheimer's disease: a hippocampal dementia","volume":"325","author":"Ball","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0195","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1176\/ajp.157.1.115","article-title":"Hippocampal volume reduction in major depression","volume":"157","author":"Bremner","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jneuroim.2006.11.017","article-title":"Inflammatory processes in Alzheimer's disease","volume":"184","author":"Heneka","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0210","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/FBP.0b013e3282de7929","article-title":"The role of hippocampus in anxiety: intracerebral infusion studies","volume":"18","author":"Engin","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0215","series-title":"Advances in Protein Chemistry and Structural Biology","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-398314-5.00001-5","article-title":"Inflammation in anxiety","author":"Salim","year":"2012"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0220","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/JGP.0b013e3181cc0333","article-title":"Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes","volume":"18","author":"Weintraub","year":"2010","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0225","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(11)60830-1","article-title":"Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial","volume":"378","author":"Banerjee","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0230","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2174\/156720512801322564","article-title":"N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease","volume":"9","author":"Olivares","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0235","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/1389450013348515","article-title":"NMDA receptors and learning and memory processes","volume":"2","author":"Castellano","year":"2001","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0240","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2009.10.014","article-title":"Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion","volume":"626","author":"Barkus","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0245","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.2174\/1381612819666140110120435","article-title":"Targeting of NMDA receptors in the treatment of major depression","volume":"20","author":"Dang","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0250","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/01.JGP.0000224350.82719.83","article-title":"M.M.-M.-10 S. Group, Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial","volume":"14","author":"Peskind","year":"2006","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0255","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","article-title":"Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial","volume":"291","author":"Tariot","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0260","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000102568","article-title":"Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials","volume":"24","author":"Winblad","year":"2007","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0265","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.wad.0000213860.35355.d4","article-title":"M.M.-M.-02 S. Group, Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis","volume":"20","author":"Schmitt","year":"2006","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0270","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1161\/01.STR.0000020094.08790.49","article-title":"Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300)","volume":"33","author":"Orgogozo","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0275","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3233\/JAD-170424","article-title":"Memantine for Alzheimer's disease: an updated systematic review and meta-analysis","volume":"60","author":"Kishi","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0280","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/mp.2016.187","article-title":"Blockade of the K ATP channel Kir6. 2 by memantine represents a novel mechanism relevant to Alzheimer's disease therapy","volume":"23","author":"Moriguchi","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0285","series-title":"Diabetic Medicine","first-page":"52","article-title":"Alzheimer's disease drug Memantine inhibits Adenosine triphosphate (ATP)-sensitive potassium (KATP) channel activation in hypothalamic GT1-7 cells","author":"Hall","year":"2018"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0290","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3233\/JAD-160543","article-title":"Subclinical doses of ATP-sensitive potassium channel modulators prevent alterations in memory and synaptic plasticity induced by amyloid-\u03b2","volume":"57","author":"Salgado-Puga","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0295","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3233\/JAD-2010-101017","article-title":"The K ATP channel activator diazoxide ameliorates amyloid-\u03b2 and Tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease","volume":"22","author":"Liu","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0300","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.bbrc.2018.04.128","article-title":"Sildenafil protects neuronal cells from mitochondrial toxicity induced by \u03b2-amyloid peptide via ATP-sensitive K+ channels","volume":"500","author":"Son","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0305","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuroscience.2016.08.034","article-title":"Aberrant expression of the pore-forming KATP channel subunit Kir6. 2 in hippocampal reactive astrocytes in the 3xTg-AD mouse model and human Alzheimer's disease","volume":"336","author":"Griffith","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2012.08.008","article-title":"A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats","volume":"254","author":"Rai","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0315","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.brainres.2005.05.049","article-title":"MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity","volume":"1050","author":"Thomas","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0320","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pbb.2011.05.016","article-title":"N-methyl-D-aspartate receptor antagonist MK-801 suppresses glial pro-inflammatory cytokine expression in morphine-tolerant rats","volume":"99","author":"Liu","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0325","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0165-5728(00)00317-9","article-title":"Role of NMDA receptor signaling in the regulation of inflammatory gene expression after focal brain ischemia","volume":"109","author":"Jander","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0330","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2006"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0335","doi-asserted-by":"crossref","DOI":"10.1134\/S1819712411030081","article-title":"Involvement of dorsal hippocampal NMDA-glutamatergic system in anxiety-related behaviors of rats","volume":"5","author":"Solati","year":"2011","journal-title":"Neurochem. J."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0340","doi-asserted-by":"crossref","first-page":"11281","DOI":"10.1038\/s41598-018-29595-0","article-title":"Small litter size impairs spatial memory and increases anxiety-like behavior in a strain-dependent manner in male mice","volume":"8","author":"Salari","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0345","doi-asserted-by":"crossref","DOI":"10.1111\/j.1440-1819.2010.02143.x","article-title":"Dorsal hippocampal opioidergic system modulates anxiety-like behaviors in adult male Wistar rats","volume":"64","author":"Solati","year":"2010","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2015.10.009","article-title":"Developmental minocycline treatment reverses the effects of neonatal immune activation on anxiety- and depression-like behaviors, hippocampal inflammation, and HPA axis activity in adult mice","volume":"120","author":"Majidi","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0355","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1212\/01.wnl.0000172351.95783.8e","article-title":"Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine","volume":"65","author":"Ridha","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0360","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/jnnp.2006.096420","article-title":"Visual hallucinations and agitation in Alzheimer's disease due to memantine: report of three cases","volume":"78","author":"Monastero","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0365","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0028-3908(93)90170-8","article-title":"Effects of 5, 7 dichlorokynurenic acid on conflict, social interaction and plus maze behaviors","volume":"32","author":"Corbett","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(89)90811-X","article-title":"Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze","volume":"169","author":"Dunn","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0375","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0924-977X(94)90299-2","article-title":"Effects of antagonists at the NMDA receptor complex in two models of anxiety","volume":"4","author":"Plaznik","year":"1994","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0380","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0924-977X(95)00068-Z","article-title":"The effects of repeated administration of diazepam, MK-801 and CGP 37849 on rat behavior in two models of anxiety","volume":"6","author":"Jessa","year":"1996","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0385","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1600-0773.1995.tb00116.x","article-title":"Characterization of the anticonflict effect of MK-801, a non-competitive NMDA antagonist","volume":"76","author":"S\u00f6derpalm","year":"1995","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0390","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0091-3057(92)90178-I","article-title":"Anxiolytic-like effects of the noncompetitive NMDA antagonist MK 801","volume":"43","author":"Xie","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0395","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0400","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.brainresbull.2009.11.013","article-title":"Neurochemical and behavioural effects of acute and chronic memantine administration in rats: further support for NMDA as a new pharmacological target for the treatment of depression?","volume":"81","author":"R\u00e9us","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0405","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1460-9568.2007.05312.x","article-title":"Impaired spatial working memory but spared spatial reference memory following functional loss of NMDA receptors in the dentate gyrus","volume":"25","author":"Niewoehner","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0410","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0896-6273(02)00830-9","article-title":"The human hippocampus and spatial and episodic memory","volume":"35","author":"Burgess","year":"2002","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.physbeh.2019.01.005_bb0415","first-page":"417","article-title":"The role of the hippocampus in the pathophysiology of major depression","volume":"29","author":"Campbell","year":"2004","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0420","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1017\/S0140525X00013066","article-title":"Pr\u00e9cis of the neuropsychology of anxiety: an enquiry into the functions of the septo-hippocampal system","volume":"5","author":"Gray","year":"1982","journal-title":"Behav. Sci. Brain"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0425","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/cyto.1997.0290","article-title":"The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and Th1-like response in stress-induced anxiety","volume":"10","author":"Maes","year":"1998","journal-title":"Cytokine"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0430","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","article-title":"Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications","volume":"246","author":"Felger","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0435","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2019.01.005_bb0440","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.nlm.2014.08.008","article-title":"Modulation of learning and memory by cytokines: signaling mechanisms and long term consequences","volume":"115","author":"Donzis","year":"2014","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0445","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbi.2010.10.015","article-title":"Immune modulation of learning, memory, neural plasticity and neurogenesis","volume":"25","author":"Yirmiya","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0450","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(99)00098-4","article-title":"Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation","volume":"106","author":"Pugh","year":"1999","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0455","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbr.2003.12.018","article-title":"Cognitive function in young and adult IL (interleukin)-6 deficient mice","volume":"153","author":"Braida","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0460","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/ajmg.b.30712","article-title":"Cognitive dysfunction in mice deficient for TNF-and its receptors","volume":"147","author":"Baune","year":"2008","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatry Genet."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0465","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.physbeh.2013.06.010","article-title":"Effects of long-term etanercept treatment on anxiety-and depression-like neurobehaviors in rats","volume":"119","author":"Bayramg\u00fcrler","year":"2013","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0470","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jpsychores.2015.04.008","article-title":"Tumour necrosis factor-\u03b1 inhibitor therapy in chronic physical illness: a systematic review and meta-analysis of the effect on depression and anxiety","volume":"79","author":"Abbott","year":"2015","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0475","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/bcpt.12037","article-title":"Chronic Administration of Infliximab (TNF-\u03b1 Inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress","volume":"112","author":"Karson","year":"2013","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0480","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neulet.2009.03.068","article-title":"Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory","volume":"456","author":"Koo","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0485","doi-asserted-by":"crossref","first-page":"7527","DOI":"10.4049\/jimmunol.166.12.7527","article-title":"Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia","volume":"166","author":"Tikka","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0490","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s002210050277","article-title":"Induction of microglial and astrocytic response in the adult rat lumbar spinal cord following middle cerebral artery occlusion","volume":"118","author":"Wu","year":"1998","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0495","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0006-8993(97)00637-9","article-title":"The N-methyl-D-aspartate (NMDA) receptor is postsynaptic to substance P-containing axon terminals in the rat superficial dorsal horn","volume":"772","author":"Aicher","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0500","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.tins.2007.07.007","article-title":"Neurotransmitter receptors on microglia","volume":"30","author":"Pocock","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0505","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0304-3940(91)90559-C","article-title":"Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate","volume":"133","author":"Piani","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0510","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/eji.1830220936","article-title":"Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines","volume":"22","author":"Piani","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0515","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/brbi.1995.1033","article-title":"Interleukin-1 and tumor necrosis factor-\u03b1 synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors","volume":"9","author":"Chao","year":"1995","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0520","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1523\/JNEUROSCI.20-01-00251.2000","article-title":"AMPA\u2013kainate subtypes of glutamate receptor in rat cerebral microglia","volume":"20","author":"Noda","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0525","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of glutamate and NMDA receptors in Alzheimer's disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.physbeh.2019.01.005_bb0530","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1002\/gps.934","article-title":"Glutamatergic systems in Alzheimer's disease","volume":"18","author":"Francis","year":"2003","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"4","key":"10.1016\/j.physbeh.2019.01.005_bb2000","first-page":"189","article-title":"Effect of Aggregated \u03b2-Amyloid (1-42) on Synaptic Plasticity of Hippocampal Dentate Gyrus Granule Cells in Vivo","volume":"2","author":"Babri","year":"2012","journal-title":"BioImpacts"}],"container-title":["Physiology & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938418310989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938418310989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T21:30:53Z","timestamp":1550611853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938418310989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":110,"alternative-id":["S0031938418310989"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2019.01.005","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NMDA receptor in the hippocampus alters neurobehavioral phenotypes through inflammatory cytokines in rats with sporadic Alzheimer-like disease","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2019.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}